Commercial Strategy
Strategy Built to Win – Not Just Look Good on Paper
From initial opportunity assessment through go-to-market planning, we help you understand if a market is viable, how to position competitively, and what path will get you there given your resource, budget, and time constraints.
HOW WE HELP CLIENTS
The gap in most commercial strategy work isn’t the opportunity—it’s the plan to actually capture it. We close that gap.
Our work moves from a clear read on where you can compete, through the positioning and pricing that make the case for you, to a go-to-market plan built around the timeline and resources you actually have—not the ones a strategy deck assumes.
We size the opportunity honestly, including the parts that are hard to hear. A market that’s technically addressable isn’t automatically worth entering, and we’ll tell you when it isn’t. That honesty is what makes the plans we do build actually get executed instead of shelved.
Our core strength is connecting the dots between what the market will support, what your organization can realistically deliver, and the specific plan that gets you from one to the other.
Competitive Positioning
Understanding your competitors isn’t enough—you need to know where you can win. We analyze competitor product portfolios, sales strategies, messaging, pricing, and market positioning to identify gaps and opportunities. Our competitive assessments go beyond features and benefits to reveal strategic vulnerabilities and differentiation opportunities that inform your positioning, messaging, and go-to-market strategy.
Market Opportunity Sizing
How big is the opportunity, really? We build bottoms-up market models that account for addressable patient populations, testing volumes, procedure rates, or customer segments—depending on your market. Our sizing goes beyond top-down TAM estimates to forecast realistic market penetration based on customer needs, competitive dynamics, reimbursement, and adoption curves. You get realistic revenue projections grounded in market realities.
Go-To Market Planning
A great strategy fails without an execution roadmap. We build go-to-market plans that connect strategy to action—defining launch timelines, channel strategies, sales coverage models, marketing tactics, partnership requirements, and success metrics. Our plans are designed to align cross-functional teams (sales, marketing, product, operations) around a common launch strategy and execution timeline.
Value Proposition Development
Your value proposition should be rooted in what customers actually care about—not what you think they care about. We conduct customer research to understand decision drivers, pain points, and purchasing criteria. Then we translate those insights into clear, compelling value propositions that resonate with target segments. The result is messaging that differentiates you and aligns with how customers make decisions.
Our Approach
We don’t deliver generic frameworks. We combine deep domain expertise with rigorous research to give you strategies grounded in market reality.
Domain Expertise
We’ve spent years working in cell and gene therapy, clinical diagnostics, medical devices, biotech, and pharma. We understand regulatory pathways, reimbursement models, customer buying behavior, and competitive dynamics. That context shapes better questions, sharper analysis, and more realistic strategies.
Research-Driven
Every recommendation is backed by primary and secondary research. We interview customers, analyze competitors, model market dynamics, and test assumptions. You don’t get opinions—you get evidence-based strategies built on what the market actually tells us.
Actionable Outcomes
We deliver strategies designed for execution. Clear recommendations, prioritized actions, and roadmaps that your team can implement. No 200-page reports that sit on a shelf—just practical strategies that move your business forward.
Commercial Strategy in Action | Entering Markets with Confidence
Highest Impact
CS #10 · COMMERCIAL STRATEGY
Program Management & Business Transformation
Taking Breakthrough Technology From Proof-of-Concept to Commercial Launch Over 2.5 Years
After five years of R&D investment, a leading bioprocessing consumables supplier had proven their capital equipment technology worked. MKA led a 2.5-year program management engagement spanning viability assessment, pricing, VOC research, NPD across 9 products, sourcing, validation, facilities, and financial modeling — concluding with 9 products at validation-ready status and purchase interest from 3 major biopharma customers.
CS #1 · COMMERCIAL STRATEGY
Commercial Viability Assessment & Strategic Pivot
How a 3-Month Assessment Prevented a Multi-Million Dollar Strategic Misstep
After five years of R&D investment, a bioprocessing supplier faced a defining decision: build direct or license through an OEM. MKA researched the landscape, interviewed prospective customers, and built scenarios comparing both paths. The finding that changed everything: this was not a product launch — it was the creation of a new business unit.
CS #2 · COMMERCIAL STRATEGY
Complex Pricing Strategy & Financial Modeling
Building a Pricing Architecture for a Multi-Revenue-Stream Capital Equipment Business
A bioprocessing supplier launching its first capital equipment product couldn’t apply existing pricing expertise to a system with 30+ cost components. MKA built a detailed cost model, established the value-based ceiling above the cost-plus floor, and developed four integrated pricing scenarios — preventing systematic underpricing at launch.
CS #17 · COMMERCIAL STRATEGY
Financial Analysis & Decision Support
Five Financial Models, Five Decisions, One 2.5-Year Engagement
A bioprocessing company needed financial analysis relevant across an entire multi-year program. MKA built five distinct frameworks serving five different decisions — from initial go/no-go through sourcing negotiations — confirming customer willingness to pay substantially above cost-plus pricing.
CS #21 · COMMERCIAL STRATEGY
Global Distribution Strategy
Turning a Chaotic Distributor Network Into a Structured Global Channel Strategy
After being acquired by a large healthcare provider, a bioprocessing company discovered it had no formal contracts, pricing transparency, or commercial leadership across its global distributor network. MKA conducted a forensic analysis of every distributor relationship, segmented partners into strategic tiers, and negotiated region-by-region contracts — replacing handshake deals with standardized terms, global pricing visibility, and a single point of accountability for the channel.
CS #22 · COMMERCIAL STRATEGY
European Market Entry Playbook
Building a European Expansion Playbook From One Successful Sales Hire to a Direct Operations Roadmap
A US-based life sciences tools company had relied on a European distribution partner, but one direct sales hire generated strong enough results to raise a bigger question: where to invest next. MKA built a comprehensive European Market Playbook covering headcount, logistics, banking, legal structure, and tax implications — with built-in flexibility that let the Company navigate Brexit-era uncertainty without losing momentum.
The MKA Partnering Imperative
A practical framework for evaluating strategic partnerships in life sciences – when to partner, how to structure the relationship and how to protect what matters.
FREE DOWNLOAD
PDF delivered to your inbox.
Ready to talk commercial strategy?
Schedule a 30-minute call to discuss your market entry, positioning, or growth challenge.